medigraphic.com
SPANISH

Revista de Gastroenterología de México

Asociación Mexicana de Gastroenterología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2006, Number 4

<< Back Next >>

Rev Gastroenterol Mex 2006; 71 (4)

Radical surgical treatment of a neuroendocrine tumor of the ileocecal valve with liver metastasis and carcinoid syndrome

Echeverría-Miranda CA, Gómez-Gómez E, Carrillo-Ponce CS, Mondragón-Sánchez A, Mondragón-Sánchez R
Full text How to cite this article

Language: Spanish
References: 0
Page: 478-482
PDF size: 157.33 Kb.


Key words:

Neuroendocrine tumors, palliative treatment, surgical treatment, liver metastasis.

ABSTRACT

Background: Neuroendocrine tumors are rare neoplasms which have a slow growth pattern. When liver metastases are diagnosed, treatment is controversial and it is focused in symptomatic control. Aim: To present a patient with a neuroendocrine tumor that arised from the ileocecal valve and it was diagnosed with carcinoid syndrome and treated with radical liver and colonic resection. A discussion of the different forms of treatment is presented. Case report: A 41 year-old woman was sent to our hospital with liver metastases and carcinoid syndrome from a neuroendocrine tumor of the ileocecal valve for treatment. Right colectomy, right hepatic trisectionectomy and radiofrequency ablation of two left sided lesions was performed as a first procedure. A second procedure was performed two months afterwards when resection of residual left sided lesions was done. After a two year follow up a 2 cm residual liver lesion was diagnosed and percutaneous radiofrequency ablation was done. After four years of follow up the patient has been asymptomatic without tumor recurrence Conclusions: Radical surgical treatment of neuroendocrine tumors controls symptomatology, improving quality of life and survival. However, this treatment should only be performed in a well selected group of patients.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Gastroenterol Mex. 2006;71